|
|
|
Volumn 5, Issue 10, 1999, Pages 2669-2671
|
|
Oral cancer chemotherapy: The promise and the pitfalls
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 ETHYNYLURACIL;
ANTHRACYCLINE ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
IDARUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
PACLITAXEL;
ACUTE LYMPHOBLASTIC LEUKEMIA;
AREA UNDER THE CURVE;
BREAST CANCER;
CANCER;
CANCER CHEMOTHERAPY;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EXPOSURE;
DRUG MONITORING;
EDITORIAL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
TITRIMETRY;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC AGENTS;
ETOPOSIDE;
HUMANS;
NEOPLASMS;
PATIENT COMPLIANCE;
|
|
EID: 0032742241
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (48)
|
|
References (21)
|
